Regulus Announces Strategic Update and Corporate Restructuring – BioSpace (press release) (blog)
Efforts Aimed at Extending Cash Runway to mid-2019 LA JOLLA, Calif., July 5, 2018 /PRNewswire/ — Regulus Therapeutics, Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced a strategic update and corporate restructuring. With the goal of extending its cash runway, Regulus has taken the…